{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:49:09Z","timestamp":1761788949341,"version":"build-2065373602"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,29]]},"DOI":"10.7759\/cureus.95709","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:43:23Z","timestamp":1761788603000},"source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Utility of the Dublin-Boston Score for Short-Term Clinical Outcomes in Moderate-to-Severe COVID-19: A Cohort Study"],"prefix":"10.7759","author":[{"given":"Divya Sai","family":"Gottipati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agieshkumar Balakrishna","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lokesh","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Pugalendhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tumbanatham","family":"Appikatala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhargav Kiran","family":"Gaddam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu N","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, et al.. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020, 382:727-33. 10.1056\/NEJMoa2001017","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106765","article-title":"Infection and transmission of SARS-CoV-2 depend on heparan sulfate proteoglycans","volume":"40","author":"Bermejo-Jambrina M","year":"2021","unstructured":"Bermejo-Jambrina M, Eder J, Kaptein TM, et al.. Infection and transmission of SARS-CoV-2 depend on heparan sulfate proteoglycans. EMBO J. 2021, 40:e106765. 10.15252\/embj.2020106765","journal-title":"EMBO J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108427","article-title":"COVID-19 pathophysiology: a review","volume":"215","author":"Yuki K","year":"2020","unstructured":"Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol. 2020, 215:108427. 10.1016\/j.clim.2020.108427","journal-title":"Clin Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou P","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, et al.. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020, 579:270-3. 10.1038\/s41586-020-2012-7","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2020.04.007","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"58","author":"Eastin C","year":"2020","unstructured":"Eastin C, Eastin T. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. J Emerg Med. 2020, 58:713-4. 10.1016\/j.jemermed.2020.04.007","journal-title":"J Emerg Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu Z","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020, 323:1239-42. 10.1001\/jama.2020.2648","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212552","article-title":"Immunobiological properties and clinical applications of interleukin-38 for immune-mediated disorders: a systematic review study","volume":"22","author":"Esmaeilzadeh A","year":"2021","unstructured":"Esmaeilzadeh A, Bahmaie N, Nouri E, Hajkazemi MJ, Zareh Rafie M. Immunobiological properties and clinical applications of interleukin-38 for immune-mediated disorders: a systematic review study. Int J Mol Sci. 2021, 22:12552. 10.3390\/ijms222212552","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed9010013","article-title":"Pro-inflammatory and anti-inflammatory interleukins in infectious diseases: a comprehensive review","volume":"9","author":"Al-Qahtani AA","year":"2024","unstructured":"Al-Qahtani AA, Alhamlan FS, Al-Qahtani AA. Pro-inflammatory and anti-inflammatory interleukins in infectious diseases: a comprehensive review. Trop Med Infect Dis. 2024, 9:13. 10.3390\/tropicalmed9010013","journal-title":"Trop Med Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1684\/ecn.2020.0448","article-title":"Interleukin-6 and severe COVID-19: a systematic review and meta-analysis","volume":"31","author":"Mojtabavi H","year":"2020","unstructured":"Mojtabavi H, Saghazadeh A, Rezaei N. Interleukin-6 and severe COVID-19: a systematic review and meta-analysis. Eur Cytokine Netw. 2020, 31:44-9. 10.1684\/ecn.2020.0448","journal-title":"Eur Cytokine Netw"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00364","article-title":"Immune parameters and COVID-19 infection - associations with clinical severity and disease prognosis","volume":"10","author":"Jesenak M","year":"2020","unstructured":"Jesenak M, Brndiarova M, Urbancikova I, et al.. Immune parameters and COVID-19 infection - associations with clinical severity and disease prognosis. Front Cell Infect Microbiol. 2020, 10:364. 10.3389\/fcimb.2020.00364","journal-title":"Front Cell Infect Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.677008","article-title":"Elevated interleukin-10 levels in COVID-19: potentiation of pro-inflammatory responses or impaired anti-inflammatory action?","volume":"12","author":"Islam H","year":"2021","unstructured":"Islam H, Chamberlain TC, Mui AL, Little JP. Elevated interleukin-10 levels in COVID-19: potentiation of pro-inflammatory responses or impaired anti-inflammatory action?. Front Immunol. 2021, 12:677008. 10.3389\/fimmu.2021.677008","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-016-0324-z","article-title":"The balance between the serum levels of IL-6 and IL-10 cytokines discriminates mild and severe acute pneumonia","volume":"16","author":"de Brito RC","year":"2016","unstructured":"de Brito RC, Lucena-Silva N, Torres LC, Luna CF, Correia JB, da Silva GA. The balance between the serum levels of IL-6 and IL-10 cytokines discriminates mild and severe acute pneumonia. BMC Pulm Med. 2016, 16:170. 10.1186\/s12890-016-0324-z","journal-title":"BMC Pulm Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s43168-021-00054-1","article-title":"Interleukin-6 and C-reactive protein\/albumin ratio as predictors of COVID-19 severity and mortality","volume":"15","author":"El-Shabrawy M","year":"2021","unstructured":"El-Shabrawy M, Alsadik ME, El-Shafei M, Abdelmoaty AA, Alazzouni AS, Esawy MM, Shabana MA. Interleukin-6 and C-reactive protein\/albumin ratio as predictors of COVID-19 severity and mortality. Egypt J Bronchol. 2021, 15:5. 10.1186\/s43168-021-00054-1","journal-title":"Egypt J Bronchol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02571-x","article-title":"Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study","volume":"18","author":"Zhang J","year":"2020","unstructured":"Zhang J, Hao Y, Ou W, et al.. Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study. J Transl Med. 2020, 18:406. 10.1186\/s12967-020-02571-x","journal-title":"J Transl Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105982","article-title":"Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies","volume":"55","author":"Zhao M","year":"2020","unstructured":"Zhao M. Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies. Int J Antimicrob Agents. 2020, 55:105982. 10.1016\/j.ijantimicag.2020.105982","journal-title":"Int J Antimicrob Agents"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12671","article-title":"Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology","volume":"285","author":"Cicchese JM","year":"2018","unstructured":"Cicchese JM, Evans S, Hult C, et al.. Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology. Immunol Rev. 2018, 285:147-67. 10.1111\/imr.12671","journal-title":"Immunol Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103026","article-title":"A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19","volume":"61","author":"McElvaney OJ","year":"2020","unstructured":"McElvaney OJ, Hobbs BD, Qiao D, et al.. A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19. EBioMedicine. 2020, 61:103026. 10.1016\/j.ebiom.2020.103026","journal-title":"EBioMedicine"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103090","article-title":"Predicting outcomes in COVID-19: from internal validation to improving care","volume":"61","author":"Taseen R","year":"2020","unstructured":"Taseen R, Cantin AM. Predicting outcomes in COVID-19: from internal validation to improving care. EBioMedicine. 2020, 61:103090. 10.1016\/j.ebiom.2020.103090","journal-title":"EBioMedicine"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"A minimal common outcome measure set for COVID-19 clinical research","volume":"20","author":"WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection","year":"2020","unstructured":"WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020, 20:e192-7. 10.1016\/S1473-3099(20)30483-7","journal-title":"Lancet Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocac041","article-title":"Developing a COVID-19 WHO Clinical Progression Scale inpatient database from electronic health record data","volume":"29","author":"Ramaswamy P","year":"2022","unstructured":"Ramaswamy P, Gong JJ, Saleh SN, McDonald SA, Blumberg S, Medford RJ, Liu X. Developing a COVID-19 WHO Clinical Progression Scale inpatient database from electronic health record data. J Am Med Inform Assoc. 2022, 29:1279-85. 10.1093\/jamia\/ocac041","journal-title":"J Am Med Inform Assoc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06155","article-title":"IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression","volume":"7","author":"Dhar SK","year":"2021","unstructured":"Dhar SK, K V, Damodar S, Gujar S, Das M. IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression. Heliyon. 2021, 7:e06155. 10.1016\/j.heliyon.2021.e06155","journal-title":"Heliyon"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2022.152236","article-title":"Deciphering the balance of IL-6\/IL-10 cytokines in severe to critical COVID-19 patients","volume":"227","author":"Azaiz MB","year":"2022","unstructured":"Azaiz MB, Jemaa AB, Sellami W, et al.. Deciphering the balance of IL-6\/IL-10 cytokines in severe to critical COVID-19 patients. Immunobiology. 2022, 227:152236. 10.1016\/j.imbio.2022.152236","journal-title":"Immunobiology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-022-07511-7","article-title":"WHO Ordinal Scale and inflammation risk categories in COVID-19. Comparative study of the severity scales","volume":"37","author":"Rubio-Rivas M","year":"2022","unstructured":"Rubio-Rivas M, Mora-Luj\u00e1n JM, Formiga F, et al.. WHO Ordinal Scale and inflammation risk categories in COVID-19. Comparative study of the severity scales. J Gen Intern Med. 2022, 37:1980-7. 10.1007\/s11606-022-07511-7","journal-title":"J Gen Intern Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S525030","article-title":"Adaptation of the WHO COVID-19 clinical progression scale for registry-based data: a whole-population study in Sweden","volume":"17","author":"Jerndal H","year":"2025","unstructured":"Jerndal H, Kalucza S, Jakobsson F, et al.. Adaptation of the WHO COVID-19 clinical progression scale for registry-based data: a whole-population study in Sweden. Clin Epidemiol. 2025, 17:663-79. 10.2147\/CLEP.S525030","journal-title":"Clin Epidemiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2478\/jccm-2023-0025","article-title":"The prognostic utility of cytokines in hospitalized COVID-19 patients","volume":"9","author":"Andrejkovits \u00c1V","year":"2023","unstructured":"Andrejkovits \u00c1V, Hu\u021banu A, Sus\u00e1nyi EJ, Negrea V, V\u0103sie\u0219iu AM. The prognostic utility of cytokines in hospitalized COVID-19 patients. J Crit Care Med (Targu Mures). 2023, 9:208-17. 10.2478\/jccm-2023-0025","journal-title":"J Crit Care Med (Targu Mures)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics","volume":"17","author":"Van Calster B","year":"2019","unstructured":"Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019, 17:230. 10.1186\/s12916-019-1466-7","journal-title":"BMC Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.09.016","article-title":"Validation of clinical prediction models: what does the \"calibration slope\" really measure?","volume":"118","author":"Stevens RJ","year":"2020","unstructured":"Stevens RJ, Poppe KK. Validation of clinical prediction models: what does the \"calibration slope\" really measure?. J Clin Epidemiol. 2020, 118:93-9. 10.1016\/j.jclinepi.2019.09.016","journal-title":"J Clin Epidemiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu207","article-title":"Towards better clinical prediction models: seven steps for development and an ABCD for validation","volume":"35","author":"Steyerberg EW","year":"2014","unstructured":"Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J. 2014, 35:1925-31. 10.1093\/eurheartj\/ehu207","journal-title":"Eur Heart J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers AJ","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006, 26:565-74. 10.1177\/0272989X06295361","journal-title":"Med Decis Making"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers AJ","year":"2019","unstructured":"Vickers AJ, van Calster B, Steyerberg EW. A simple, step-by-step guide to interpreting decision curve analysis. Diagn Progn Res. 2019, 3:18. 10.1186\/s41512-019-0064-7","journal-title":"Diagn Progn Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/325095-prognostic-utility-of-the-dublin-boston-score-for-short-term-clinical-outcomes-in-moderate-to-severe-covid-19-a-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:43:23Z","timestamp":1761788603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/325095-prognostic-utility-of-the-dublin-boston-score-for-short-term-clinical-outcomes-in-moderate-to-severe-covid-19-a-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.95709","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}